APPLICATIONS PUBLISHED 4 SEPTEMBER 2002
Published: 1-Mar-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Cosmetic and/or pharmaceutical compsns containing dicarboxylic acid monoesters
Cognis Deutschland 1235553*
Powder to liquid compsns
Color Access 1235554*
Stable galenic preparations comprising a benzimidazol and method for the preparation thereof
Ratiopharm 1235555*
Taste masking coating compsns
Ranbaxy Laboratories 1235556*
Gastroretentive controlled release pharmaceutical dosage forms
Yissum Research Development Company of the Hebrew University of Jerusalem 1235557*
Compressed tablet compsn
The Boots Company 1235558*
Solid oral dosage form
Shire Laboratories 1235559*
Microchip devices for delivery of molecules and methods of fabrication thereof
Massachusetts Institute of Technology 1235560*
Fast dissolving compsn with prolonged sweet taste
Panacea Biotec 1235561*
Chronotherapeutic diltiazem formulations and the administration thereof
Biovail Laboratories 1235562*
Use of anti(W)pressor agents for vascular remodelling in genital dysfunction
Queen's University at Kingston 1235563*
Triiodomethane thickener conjugates, a method for their production and their use as disinfectant cleaners and hygiene products
Doht, Ulrich 1235564*
Use of 5HT 3 agonists for relaxing the fundus
Janssen Pharmaceutica 1235565*
Valnemulin formulation
Novartis 1235566*
Inhibitors of collagen-induced platelet aggregation
Parker Hughes Institute 1235567*
Depletion of cellular coenzyme A levels as a means to selectively kill cancer cells
The Johns Hopkins University School of Medicine 1235568*
Medicament and combination of compatible medicaments
November Aktiengesellschaft Gesellschaft fuer Molekulare Medizin 1235569*
Combinations of (2)-2-(benzylamino-methyl)-2,3,8,9-tetrahydro-7H-1,4-dioxino(2,3)-E indol-8-one and neuroleptics
Wyeth 1235570*
Use of melatonin for treating androgenetic and diffuse alopecia
Asat AG Applied Science and Technology 1235571*
Method to treat pain utilising benzimidazole NMDA/NR2B antagonists
Merck Sharp & Dohme 1235572*
Combination of riluzole and gabapentin and use thereof as a medicine
Aventis Pharma 1235573*
Methods for making sustained-release pharmaceutical compsns of ergot alkaloids having improved bioavailability and compsns thereof
Aventis Pharma 1235574*
Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somastatin activation property
Fukisawa Pharmaceutical 1235575*
Combinations of sumitriptan or naratriptan with cyclooxygenase II inhibitor
Glaxo Group 1235576*
Protease inhibitors
SmithKline Beecham 1235577*
Use of hymenialdisine or derivatives thereof in the manufacture of medicaments
Centre National de la Recherche Scientifique 1235578*
Pharmaceutical compsns comprising trimegestone
Aventis Pharma 1235579*
Transdermal system containing acetylsalicylic acid for treatment of migraine
LTS Lohmann Therapie-Systeme 1235580*
Use of ribose to prevent cramping and soreness in muscles
Bioenergy 1235581*
Methods and kits for use in preventing restenosis
Corazon Technologies 1235582*
Process for the extraction of valerian root
Ancile Pharmaceuticals 1235583*
Virus immunologic determinants
Cell Genesys 1235584*
Use of a milk protein hydrolysate in the treatment of diabetes
Societe des Produits Nestle 1235585*
Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
University of Southern California 1235586*
Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases comprising all-D peptides
Neurochem 1235587*
Systemic immune response induced by mucosal administration of lipid-tailed polypeptides without adjuvant
Institut Pasteur 1235588*
Compsns comprising Neisseria meningitidis antigens from sero-groups B and C as well as a further antigen
Chiron 1235589*
A method of treating a malignancy in a subject and a pharmaceutical compsn for use in same
The University of Newcastle Research Associates 1235590*
Vaccine adjuvants comprising ginseng plant extracts and added aluminium salt
Statens Veterinaermedicinska Anstalt 1235591*
Combination of compounds that inhibit the biological effects of TNFa and CD95L in a medicament
Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts 1235592*
Hyperoncotic artifical cerebrospinal fluid and method of treating neural tissue edema therewith
Neuron Therapeutics 1235593*
Inhibition of secretion from non-neuronal cells
Microbiological Research Authority, CAMR 1235594*
Integrin-mediated drug targeting
Bayer 1235595*
Use of lytic toxins and toxin conjugates
Microbiological Research Authority, CAMR 1235596*
Nucleic acid delivery system
Pharmaconcepts 1235597*
Compsns of a combination of radioactive therapy and cell-cycle inhibitors
Angiotech Pharmaceuticals 1235598*
